Treatment of chronic viral hepatitis B using pegylated interferon alpha-2a – presentation of selected cases
Robert Pleśniak | Marcin Hawro
Treatment of chronic viral hepatitis B using pegylated interferon alpha-2a – presentation of selected cases
Robert Pleśniak | Marcin Hawro
Caspofungin (Cancidas®) in the treatment for Candida albicans meningitis
Dorota Czechowska1 | Urszula Dziuk2 | Mariusz Czechowski3
Rifaximin in prevention and treatment of hepatic encephalopathy
Henryka Mięgoć | Marta Piekarska | Alicja D. Wandałowicz
Pertussis – reemerging infectious disease. Clinical scenario with overview of the current epidemic situation and the disease prevention
Ernest Kuchar1 | Aneta Nitsch-Osuch2 | Leszek Szenborn1
Changes in characteristic of antimalarial drug Malarone® (atovaquone/proguanil)
Piotr Kajfasz
Hand hygiene as a duty of health care personnel having contact with the patients
Maria Ciuruś
Do cotton fabrics – surgical drapes and reusable gowns – pose a danger to patients and medical staff in high-risk procedures?
Beata Sokół-Leszczyńska1 | Piotr Leszczyński1, 2 | Marta Wróblewska1, 3
Diagnostics and screening of MRSA infections
Edyta Podsiadły1 | Urszula Demkow1, 2
Prevention of the digestive system disorders during treatment with macrolide antibiotics
Ariel Liebert1, 2 | Ewelina Kałużna3 | Maria Kłopocka1, 2
Clinical significance of Stenotrophomonas maltophilia
Dorota Bartoszek1 | Małgorzata Fleischer2